Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 856 to 870 of 1364 results for social care

  1. What is the relative effectiveness and cost effectiveness of the different components of multi-component, community-based oral health improvement programmes?

    Non-clinical outcomes should include the use of non-dental health and social care services by children and adults, such as numbers...

    Research recommendation
    Published
    9 June 2015

  2. Osimertinib for untreated EGFR mutation-positive non-small-cell lung cancer (TA654)

    Evidence-based recommendations on osimertinib (Tagrisso) for untreated locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer in adults.

    Technology appraisal guidance
    Published
    14 October 2020

    Sections for TA654

  3. Support to carers and practitioners to help young people's independence:- What is the most effective way to help carers and practitioners support young people's independence?

    from children's to adults' services for young people using health or social care services Number NG43 Date issued February 2016

    Research recommendation
    Published
    21 March 2016

  4. Joint commissioning arrangements: What are the most effective joint commissioning arrangements for disabled children and young people with severe complex needs?

    complex needs: integrated service delivery and organisation across health, social care and education Number NG213 Date issued March 2022

    Research recommendation
    Published
    8 April 2022

  5. What community-based interventions are effective and cost effective at improving the uptake of, and reducing inequalities in the use of, dental services by groups of adults and children at high risk of poor oral health?

    Non-clinical outcomes should include the use of non-dental health and social care services by children and adults, such as numbers...

    Research recommendation
    Published
    9 June 2015

  6. Gilteritinib for treating relapsed or refractory acute myeloid leukaemia (TA642)

    Evidence-based recommendations on gilteritinib (Xospata) for relapsed or refractory FLT3-mutation-positive acute myeloid leukaemia in adults.

    Technology appraisal guidance
    Published
    12 August 2020
    View recommendations

    Sections for TA642

  7. The consequences and costs of poor transition:- What are the consequences and the costs of young people with ongoing needs not making a transition into adult services, or being poorly supported through the process?

    from children's to adults' services for young people using health or social care services Number NG43 Date issued February 2016

    Research recommendation
    Published
    21 March 2016

  8. Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea (TA777)

    Evidence-based recommendations on solriamfetol (Sunosi) for treating excessive daytime sleepiness caused by obstructive sleep apnoea in adults.

    Technology appraisal guidance
    Published
    9 March 2022
    View recommendations

    Sections for TA777

  9. Thyroid cancer: assessment and management (NG230)

    This guideline covers diagnosis and management of thyroid cancer in people aged 16 and over. It aims to reduce variation in practice and increase the quality of care and survival for people with thyroid cancer.

    NICE guideline
    Published
    19 December 2022
    View recommendations

    Sections for NG230

  10. One-piece closed bags for colostomies: late-stage assessment (HTG754)

    Late stage assessment (LSA) guidance on one-piece closed bags for colostomies

    HealthTech guidance
    Published
    10 July 2025
    View recommendations

    Sections for HTG754

  11. Berotralstat for preventing recurrent attacks of hereditary angioedema (TA738)

    Evidence-based recommendations on berotralstat (Orladeyo) for preventing recurrent attacks of hereditary angioedema in people 12 years and older.

    Technology appraisal guidance
    Published
    20 October 2021
    View recommendations

    Sections for TA738

  12. Supporting young people to manage their conditions:- What is the relationship between transition and subsequent self-management?

    from children's to adults' services for young people using health or social care services Number NG43 Date issued February 2016

    Research recommendation
    Published
    21 March 2016

  13. Nalmefene for reducing alcohol consumption in people with alcohol dependence (TA325)

    Evidence-based recommendations on nalmefene (Selincro) for reducing alcohol consumption in adults with alcohol dependence.

    Technology appraisal guidance
    Published
    26 November 2014
    View recommendations

    Sections for TA325

  14. Physical activity: for NHS staff, patients and carers (QS84)

    This quality standard covers encouraging physical activity in people of all ages who are in contact with the NHS, including staff, patients and carers. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    25 March 2015
    View quality statements

    Sections for QS84

  15. Mollii suit for spasticity (MIB100)

    NICE has a developed medtech innovation briefing on Mollii suit for spasticity .

    Medtech innovation briefing
    Published
    28 March 2017